13F Insight
DOSSIER · 13F Holders · Q2 2026

Anbio Biotechnology Ltd

13 institutions still hold Anbio Biotechnology Ltd as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP G0367B105·13 13F holders·last filed Jun 30, 2026
Market cap
—
13F value held
$985K
visible holders
Holders
13
filers reporting
Concentration
37.21%
GEODE CAPITAL MANAGEMENT, LLC #1
top holder share
AI Holders Summary · Q2 2026

13 institutions reported Anbio Biotechnology Ltd in Q2 2026. GEODE CAPITAL MANAGEMENT, LLC leads at 37.2% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
GEODE CAPITAL MANAGEMENT, LLC
CIK 0001214717· Index
$367K27K0.00%Q2 202602
BANK OF AMERICA CORP /DE/
CIK 0000070858
$184K13K0.00%Q2 202603
BNP PARIBAS FINANCIAL MARKETS
CIK 0001166588
$162K12K0.00%Q2 202604
MARSHALL WACE, LLP
CIK 0001318757
$158K12K0.00%Q2 202605
MORGAN STANLEY
CIK 0000895421
$99K7K0.00%Q2 202606
UBS Group AG
CIK 0001610520
$11K8280.00%Q2 202607
EverSource Wealth Advisors, LLC
CIK 0001710537
$3K1870.00%Q2 202608
OSAIC HOLDINGS, INC.
CIK 0001677044
$1K770.00%Q2 202609
JPMORGAN CHASE & CO
CIK 0000019617
$718530.00%Q2 202610
Bare Financial Services, Inc
CIK 0002009426
$206150.00%Q2 202611
Larson Financial Group LLC
CIK 0001731061
$6950.00%Q2 202612
Silver Grove Financial Group, Inc.
CIK 0002111172
$5540.00%Q2 202613
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
CIK 0000752798
$00—Q2 2025